ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 64 filers reported holding ANAVEX LIFE SCIENCES CORP in Q3 2017. The put-call ratio across all filers is 16.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $207 | +2.5% | 40,612 | +87.5% | 0.02% | 0.0% |
| Q4 2023 | $202 | +114.9% | 21,658 | +88.2% | 0.02% | +128.6% |
| Q2 2023 | $94 | -84.0% | 11,507 | -83.2% | 0.01% | -88.7% |
| Q1 2023 | $586 | +113.9% | 68,365 | +130.9% | 0.06% | +72.2% |
| Q4 2022 | $274 | -99.9% | 29,614 | +90.8% | 0.04% | +28.6% |
| Q4 2021 | $269,000 | -85.5% | 15,523 | -80.8% | 0.03% | -84.4% |
| Q2 2021 | $1,852,000 | +2186.4% | 81,011 | +438.3% | 0.18% | +1900.0% |
| Q4 2020 | $81,000 | -42.1% | 15,050 | -51.1% | 0.01% | -62.5% |
| Q3 2020 | $140,000 | +122.2% | 30,746 | +138.3% | 0.02% | +242.9% |
| Q2 2020 | $63,000 | -28.4% | 12,903 | -62.0% | 0.01% | -22.2% |
| Q4 2019 | $88,000 | -44.7% | 33,935 | -32.7% | 0.01% | -25.0% |
| Q3 2019 | $159,000 | +4.6% | 50,439 | +1.7% | 0.01% | +33.3% |
| Q1 2019 | $152,000 | +49.0% | 49,580 | +101.0% | 0.01% | +80.0% |
| Q3 2017 | $102,000 | – | 24,671 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AllSquare Wealth Management LLC | 51,966 | $219,297 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 220,860 | $932 | 0.06% |
| SAXON INTERESTS, INC. | 26,699 | $112,670 | 0.05% |
| Hikari Power Ltd | 85,585 | $361 | 0.03% |
| Sculptor Capital LP | 371,400 | $1,567,308 | 0.03% |
| Sculptor Capital LP | 370,400 | $1,563,088 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 94,578 | $399,119 | 0.02% |
| Opus Capital Group, LLC | 32,700 | $138 | 0.02% |
| Hayek Kallen Investment Management | 11,863 | $50 | 0.02% |
| Geneos Wealth Management Inc. | 89,725 | $378,640 | 0.02% |